Rajwinder Kaur
About Rajwinder Kaur
Data last updated:
Rajwinder Kaur is a Director at Signoret Pharmaceuticals Private Limited (since 2019) and Director at Capcure Pharmaceuticals Private Limited (since 2019). The companies operate in Pharma. The largest current company by reported revenue is Signoret Pharmaceuticals Private Limited at ₹3.50 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Signoret Pharmaceuticals Private Limited U24290PB2019PTC049073 | Director | 19 Feb 2019 | 2019 | ₹3.50 Cr (FY 2025) | Active |
| Capcure Pharmaceuticals Private Limited U52609PB2019PTC049537 | Director | 29 May 2019 | 2019 | Active |
Board colleagues of Rajwinder Kaur
| Name | DIN | Company | Designation |
|---|---|---|---|
| Jaswinder Singh | 08466268 | Signoret Pharmaceuticals Private Limited , Capcure Pharmaceuticals Private Limited | Director |
| Simranjeet Singh | 08367199 | Signoret Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rajwinder Kaur
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rajwinder Kaur
Rajwinder Kaur currently holds 2 directorships: Signoret Pharmaceuticals Private Limited (Director, since 19 Feb 2019, revenue ₹3.50 Cr (FY 2025)); Capcure Pharmaceuticals Private Limited (Director, since 29 May 2019).
Rajwinder Kaur was first appointed on 19 Feb 2019 as Director at Signoret Pharmaceuticals Private Limited.
The current boards of Rajwinder Kaur's companies include Jaswinder Singh (Signoret Pharmaceuticals Private Limited), Simranjeet Singh (Signoret Pharmaceuticals Private Limited).